All Relations between Neuromuscular Diseases and decision making
| Publication | Sentence | Publish Date | Extraction Date | Species |
|---|---|---|---|---|
| Carmela Rita Balistreri, Claudia Vinciguerra, Daniele Magro, Vincenzo di Stefano, Roberto Monaster. Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets. Autoimmunity reviews. 2024-10-19. PMID:39426579. | neuromuscular diseases, is an important goal for both clinicians and researchers and should guide clinical decision-making and personalized treatment plans. | 2024-10-19 | 2024-10-22 | Not clear |
| Wolfgang Müllge. [Weaning--definition and clinical context from the neurologist's view]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS. vol 48. issue 10. 2014-06-30. PMID:24193687. | in degenerative terminally decompensated neuromuscular disease, an exact diagnosis and information is essential to help the patient in decision-making towards terminal weaning or long-term home ventilatory support. | 2014-06-30 | 2023-08-12 | Not clear |
| A Lisson. Tracheostomy and mechanical ventilation in ventilatory failure of patients with neuromuscular disease. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. vol 50. issue 3. 1995-10-11. PMID:7663497. | decision-making about tracheostomy as a treatment of ventilatory failure in patients with neuromuscular disease is complicated by problems of several kinds (medical, surgical, psychological, ethical and social). | 1995-10-11 | 2023-08-12 | Not clear |